BMJ Open Gastroenterology (Jun 2019)

Novel mainstream capnometer system is safe and feasible even under CO2 insufflation during ERCP-related procedure: a pilot study

  • Haruhiko Ogata,
  • Takanori Kanai,
  • Yoichi Takimoto,
  • Eisuke Iwasaki,
  • Tatsuhiro Masaoka,
  • Seiichiro Fukuhara,
  • Shintaro Kawasaki,
  • Takashi Seino,
  • Tadashi Katayama,
  • Kazuhiro Minami,
  • Hiroki Tamagawa,
  • Yujiro Machida

DOI
https://doi.org/10.1136/bmjgast-2018-000266
Journal volume & issue
Vol. 6, no. 1

Abstract

Read online

Background and aimsThere is a need to safely achieve conscious sedation during endoscopic retrograde cholangiopancreatography (ERCP). We evaluated the safety and feasibility of a mainstream capnometer system to monitor apnoea during ERCP under CO2 insufflation.MethodsNon-intubated adult patients undergoing ERCP-related procedures with intravenous sedation were enrolled. End-tidal CO2 (EtCO2) was continuously monitored during the procedure under CO2 insufflation using a mainstream capnometer system, comprising a capnometer and a specially designed bite block for upper gastrointestinal endoscopy and ERCP. Oxygen saturation (SpO2) was also monitored continuously during the procedure. In this study, we evaluated the safety and feasibility of the capnometer system.ResultsEleven patients were enrolled. Measurement of EtCO2 concentration was possible from the beginning to the end of the procedure in all 11 cases. There was no measurement failure, dislocation of the bite block, or adverse event related to the bite block. Apnoea linked to hypoxaemia occurred five times (mean duration, 174.4 s).ConclusionThis study confirmed that apnoea was detected earlier than when using a percutaneous oxygen monitor. Measurement of EtCO2 concentration using the newly developed mainstream capnometer system was feasible and safe even under CO2 insufflation.